1 |
2011-2012 seasonal flu vaccine intramuscular |
- |
- |
- |
- |
003 2件: 3 , 113 💬 |
2 |
2011-2012 seasonal flu vaccine subcutaneous |
- |
- |
- |
- |
003 2件: 3 , 113 💬 |
3 |
4-aminopyridine |
Dalfampridine |
1件: D04127 D04127 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
003 2件: 3 , 13 💬 |
4 |
4-cholesten-3-one, oxime |
- |
- |
- |
- |
002 2件: 2 , 3 💬 |
5 |
4-cholesten-3-one,oxime |
- |
- |
- |
- |
003 1件: 3 💬 |
6 |
Adipose derived mesenchymal stem cell |
- |
- |
- |
- |
003 1件: 3 💬 |
7 |
Air |
- |
- |
- |
- |
003 7件: 3 , 51, 58, 85, 97, 193, 299 💬 |
8 |
Amifampridine |
Amifampridine |
1件: D10228 D10228 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
003 3件: 3 , 11, 12 💬 |
9 |
Amifampridine phosphate |
Amifampridine |
1件: D10228 D10228 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
003 3件: 3 , 11, 12 💬 |
10 |
Amifampridine phosphate 10 mg oral tablet |
Amifampridine |
1件: D10228 D10228 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
003 1件: 3 💬 |
11 |
Avxs-101 |
- |
- |
- |
- |
003 1件: 3 💬 |
12 |
Avxs-101 (previously known as scaav9.cb.smn) |
- |
- |
- |
- |
003 1件: 3 💬 |
13 |
Biocarn |
- |
- |
- |
- |
003 1件: 3 💬 |
14 |
Branaplam |
Branaplam |
- |
- |
- |
003 1件: 3 💬 |
15 |
Celecoxib |
Celecoxib |
1件: D00567 D00567 💬 |
PTGS2 1件: PTGS2 💬 |
Alzheimer disease 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
002 9件: 2 , 3 , 34, 46, 70, 89, 161, 171, 271 💬 |
16 |
Gh |
- |
- |
- |
- |
003 1件: 3 💬 |
17 |
Human anti-promyostatin monoclonal antibody |
- |
- |
- |
- |
003 1件: 3 💬 |
18 |
Hydroxyurea |
Hydroxyurea |
1件: D00341 D00341 💬 |
RRM2 1件: RRM2 💬 |
Drug metabolism - other enzymes 6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway |
003 8件: 3 , 13, 19, 20, 65, 85, 86, 284 💬 |
19 |
Isis 396443 |
- |
- |
- |
- |
003 1件: 3 💬 |
20 |
Isis 396443 (biib058) |
- |
- |
- |
- |
003 1件: 3 💬 |
21 |
Isis 396443, biib058 |
- |
- |
- |
- |
003 1件: 3 💬 |
22 |
Itraconazole |
Itraconazole |
1件: D00350 D00350 💬 |
- |
- |
003 4件: 3 , 65, 227, 299 💬 |
23 |
Leuprolide |
Leuprolide |
2件: D00989 D00989, D08113 D08113 💬 |
GNRHR 1件: GNRHR 💬 |
GnRH signaling pathway 2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction |
001 5件: 1 , 2 , 3 , 51, 76 💬 |
24 |
Levocarnitine |
Levocarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
003 3件: 3 , 53, 97 💬 |
25 |
Lmi070 |
- |
- |
- |
- |
003 1件: 3 💬 |
26 |
Mestinon |
- |
- |
- |
- |
003 3件: 3 , 6 , 11 💬 |
27 |
Midazolam |
Midazolam |
3件: D00550 D00550, D00696 D00696, D05028 D05028 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
002 11件: 2 , 3 , 6 , 13, 21, 46, 70, 96, 97, 231, 298 💬 |
28 |
N.a. |
- |
- |
- |
- |
003 10件: 3 , 6 , 8 , 13, 46, 96, 97, 240, 256, 271 💬 |
29 |
Nerve growth factor |
Nerve Growth Factor |
- |
- |
- |
003 2件: 3 , 90 💬 |
30 |
Norditropin simplexx |
- |
- |
- |
- |
003 4件: 3 , 78, 193, 195 💬 |
31 |
Norditropin simplexx 15 mg/1.5 ml |
- |
- |
- |
- |
003 1件: 3 💬 |
32 |
Nursinersen |
- |
- |
- |
- |
003 1件: 3 💬 |
33 |
Nusinersen |
Nusinersen |
1件: D10881 D10881 💬 |
SMN2 1件: SMN2 💬 |
RNA transport 1件: RNA transport |
003 1件: 3 💬 |
34 |
Nusinersen injectable product |
Nusinersen |
1件: D10881 D10881 💬 |
SMN2 1件: SMN2 💬 |
RNA transport 1件: RNA transport |
003 1件: 3 💬 |
35 |
Nusinersen sodium |
Nusinersen |
1件: D10881 D10881 💬 |
SMN2 1件: SMN2 💬 |
RNA transport 1件: RNA transport |
003 1件: 3 💬 |
36 |
Nusinersen treatments |
Nusinersen |
1件: D10881 D10881 💬 |
SMN2 1件: SMN2 💬 |
RNA transport 1件: RNA transport |
003 1件: 3 💬 |
37 |
Olesoxime |
- |
- |
- |
- |
002 2件: 2 , 3 💬 |
38 |
Onasemnogene abeparvovec |
Onasemnogene abeparvovec |
1件: D11559 D11559 💬 |
SMN1 1件: SMN1 💬 |
RNA transport 1件: RNA transport |
003 1件: 3 💬 |
39 |
Onasemnogene abeparvovec-xioi |
Onasemnogene abeparvovec |
1件: D11559 D11559 💬 |
SMN1 1件: SMN1 💬 |
RNA transport 1件: RNA transport |
003 1件: 3 💬 |
40 |
Orfiril saft |
- |
- |
- |
- |
003 1件: 3 💬 |
41 |
Other: monthly assessments of functional motor abilities by a trained therapist |
- |
- |
- |
- |
003 1件: 3 💬 |
42 |
Other: prospective observational registry |
- |
- |
- |
- |
003 1件: 3 💬 |
43 |
Paracetamol |
Acetaminophen |
1件: D00217 D00217 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
003 5件: 3 , 6 , 13, 35, 46 💬 |
44 |
Paracetamol 120mg/5ml oral suspension |
Acetaminophen |
1件: D00217 D00217 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
003 1件: 3 💬 |
45 |
Phenylbutyrate |
Phenylbutyric acid |
1件: D05868 D05868 💬 |
- |
- |
002 11件: 2 , 3 , 6 , 8 , 15, 93, 94, 244, 251, 297, 299 💬 |
46 |
Phosphate |
Phosphate ion |
- |
- |
- |
002 30件: 2 , 3 , 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 256, 276, 283, 284, 285, 286, 299 💬 |
47 |
Placebo |
- |
- |
- |
- |
003 26件: 3 , 5 , 6 , 13, 14, 37, 40, 46, 49, 50, 51, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬 |
48 |
Procedure: air stacking manuever |
- |
- |
- |
- |
003 1件: 3 💬 |
49 |
Procedure: sham procedure |
- |
- |
- |
- |
003 1件: 3 💬 |
50 |
Pyridostigmine |
Pyridostigmine |
1件: D00487 D00487 💬 |
ACHE 1件: ACHE 💬 |
Cholinergic synapse 2件: Cholinergic synapse, Glycerophospholipid metabolism |
003 4件: 3 , 6 , 11, 256 💬 |
51 |
Pyridostigmine bromide |
Pyridostigmine |
1件: D00487 D00487 💬 |
ACHE 1件: ACHE 💬 |
Cholinergic synapse 2件: Cholinergic synapse, Glycerophospholipid metabolism |
003 3件: 3 , 6 , 256 💬 |
52 |
Reldesemtiv |
Reldesemtiv |
1件: D11363 D11363 💬 |
TNNC2 1件: TNNC2 💬 |
Calcium signaling pathway 1件: Calcium signaling pathway |
002 2件: 2 , 3 💬 |
53 |
Reldesemtiv 150 mg |
Reldesemtiv |
1件: D11363 D11363 💬 |
TNNC2 1件: TNNC2 💬 |
Calcium signaling pathway 1件: Calcium signaling pathway |
003 1件: 3 💬 |
54 |
Reldesemtiv 450 mg |
Reldesemtiv |
1件: D11363 D11363 💬 |
TNNC2 1件: TNNC2 💬 |
Calcium signaling pathway 1件: Calcium signaling pathway |
003 1件: 3 💬 |
55 |
Riluzole |
Riluzole |
1件: D00775 D00775 💬 |
GRIA1 14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway |
002 8件: 2 , 3 , 5 , 8 , 13, 17, 18, 206 💬 |
56 |
Risdiplam |
Risdiplam |
1件: D11406 D11406 💬 |
SMN2 1件: SMN2 💬 |
RNA transport 1件: RNA transport |
003 1件: 3 💬 |
57 |
Ro6885247 |
- |
- |
- |
- |
003 1件: 3 💬 |
58 |
Ro6885247/f02 |
- |
- |
- |
- |
003 1件: 3 💬 |
59 |
Ro6885247/f03 |
- |
- |
- |
- |
003 1件: 3 💬 |
60 |
Ro7034067 |
- |
- |
- |
- |
003 1件: 3 💬 |
61 |
Ro7034067 / f12 |
- |
- |
- |
- |
003 1件: 3 💬 |
62 |
Ro7034067 / f13 |
- |
- |
- |
- |
003 1件: 3 💬 |
63 |
Ro7034067/f06 + solvente (ro |
- |
- |
- |
- |
003 1件: 3 💬 |
64 |
Ro7034067/f06 with solvent (ro7034067/f08) |
- |
- |
- |
- |
003 1件: 3 💬 |
65 |
Ro7034067/f07 + solvente (ro |
- |
- |
- |
- |
003 1件: 3 💬 |
66 |
Ro7034067/f07 with solvent (ro7034067/f09) |
- |
- |
- |
- |
003 1件: 3 💬 |
67 |
Ro7034067/f12 |
- |
- |
- |
- |
003 1件: 3 💬 |
68 |
Ro7034067/f13 |
- |
- |
- |
- |
003 1件: 3 💬 |
69 |
Ro7090919 |
- |
- |
- |
- |
003 1件: 3 💬 |
70 |
Rvg 03820 |
- |
- |
- |
- |
003 1件: 3 💬 |
71 |
Salbutamol |
Salbutamol |
1件: D02147 D02147 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
003 9件: 3 , 11, 49, 85, 86, 111, 228, 256, 299 💬 |
72 |
Sesame oil |
Sesame oil |
1件: D03314 D03314 💬 |
- |
- |
003 1件: 3 💬 |
73 |
Sesame oil, refined |
Sesame oil |
1件: D03314 D03314 💬 |
- |
- |
003 1件: 3 💬 |
74 |
Smart |
- |
- |
- |
- |
003 1件: 3 💬 |
75 |
Sodium phenylbutyrate |
Phenylbutyric acid |
1件: D05868 D05868 💬 |
- |
- |
002 4件: 2 , 3 , 8 , 251 💬 |
76 |
Sodium phenylbutyrate (napb) |
Phenylbutyric acid |
1件: D05868 D05868 💬 |
- |
- |
003 1件: 3 💬 |
77 |
Somatotropin |
Somatotropin |
1件: D02691 D02691 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
003 3件: 3 , 78, 236 💬 |
78 |
Somatropin |
Somatotropin |
1件: D02691 D02691 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
002 16件: 2 , 3 , 19, 46, 74, 75, 78, 96, 113, 187, 193, 195, 265, 274, 276, 299 💬 |
79 |
Spinraza |
- |
- |
- |
- |
003 1件: 3 💬 |
80 |
Srk-015 |
- |
- |
- |
- |
003 1件: 3 💬 |
81 |
Survival of motor neuron 2 (smn2) splicing modulator antisense oligonucleotide |
- |
- |
- |
- |
003 1件: 3 💬 |
82 |
Testosterone |
Testosterone |
6件: D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D06085 D06085, D06087 D06087 💬 |
AR 1件: AR 💬 |
Oocyte meiosis 3件: Oocyte meiosis, Pathways in cancer, Prostate cancer |
001 8件: 1 , 2 , 3 , 13, 60, 78, 113, 265 💬 |
83 |
Tro19622 |
TRO19622 |
- |
- |
- |
002 3件: 2 , 3 , 13 💬 |
84 |
Valproate |
Valproic acid |
1件: D00399 D00399 💬 |
ABAT 7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism 17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
002 6件: 2 , 3 , 90, 102, 233, 256 💬 |
85 |
Valproate sodium |
Valproic acid |
1件: D00399 D00399 💬 |
ABAT 7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism 17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
003 1件: 3 💬 |
86 |
Valproate, levocarnitine |
Levocarnitine |
4件: D00399 D00399, D02030 D02030, D02176 D02176, D04713 D04713 💬 |
ABAT 7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism 17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
003 1件: 3 💬 |
87 |
Valproic acid |
Valproic acid |
1件: D00399 D00399 💬 |
ABAT 7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism 17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
003 10件: 3 , 5 , 26, 34, 65, 89, 90, 222, 256, 331 💬 |
88 |
Valproic acid (vpa) |
Valproic acid |
1件: D00399 D00399 💬 |
ABAT 7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism 17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
003 1件: 3 💬 |
89 |
Valproic acid and levocarnitine |
Levocarnitine |
4件: D00399 D00399, D02030 D02030, D02176 D02176, D04713 D04713 💬 |
ABAT 7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism 17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
003 1件: 3 💬 |
90 |
Volmax*30cpr 4mg r.p. |
- |
- |
- |
- |
003 1件: 3 💬 |
91 |
Vpa |
- |
- |
- |
- |
003 1件: 3 💬 |
92 |
Zolgensma |
- |
- |
- |
- |
003 1件: 3 💬 |